Expanded Access to ABBV-8E12
NCT03744546
·
clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Primary Tauopathy Corticobasal Degeneration Syndrome (CBD)
Interventions
DRUG:
ABBV-8E12
Sponsor
AbbVie